A Foreign Pharmaceutical Company’s Guide to Market Entry in Kenya

A pharmaceutical company market entry into Kenya, whether by a foreign pharmaceutical business or a healthtech company, faces a sequence of decisions before it ships a single product: what legal entity to register, whether any ownership restriction applies to what it wants to do, how to get its own people into the country to run the operation, and in what order to approach the regulators. Getting the sequence wrong is the most common way market entry stalls. This article sets out that sequence.

Choosing between a Kenyan subsidiary and a branch of the foreign company

A foreign investor has two realistic structures. The first is a private company limited by shares, incorporated in Kenya as a new subsidiary, registered through the Business Registration Service via eCitizen and resulting in a certificate of incorporation, a CR12 listing directors and shareholders, and a company KRA PIN. The second is registering the foreign company itself as a branch under Part XXXVII of the Companies Act, 2015. Branch registration requires lodging a certified copy of the company’s certificate of incorporation from its home jurisdiction, a certified copy of its constitution, particulars of its directors and shareholders, notice of its Kenyan registered office, and the appointment of a local representative authorised to accept service on its behalf. There is no separate statutory category for an informal “representative office”; a company wanting a presence short of full operations still registers as either a subsidiary or a branch, and simply scales down what that entity actually does.

No general minimum capital, but pharmacy ownership is restricted to registered professionals

Kenya does not impose a general minimum share capital requirement on a foreign-owned private company. Where the plan involves operating the company’s own licensed pharmacy premises, rather than supplying the Kenyan market through independent licensed distributors, a narrower rule matters more than any capital threshold. The Pharmacy and Poisons Board’s Guidelines for Registration and Licensing of Premises provide that a pharmacy business may not operate in Kenya unless everyone holding a financial interest in it is a registered pharmacist or an enrolled pharmaceutical technologist. This is a professional-registration requirement rather than a nationality bar, but it has the same practical effect for a foreign investor: a company intending to hold its own retail or wholesale pharmacy licence needs a registered pharmacist or pharmaceutical technologist among the holders of the financial interest, which usually means structuring the licensed entity separately from the parent’s general corporate ownership, or partnering with a locally registered professional. A company that will only manufacture, register products, and sell through independent licensed distributors is not caught by this particular rule, since it never itself holds a pharmacy premises licence.

The investor work permit and KenInvest’s Investment Certificate

Under section 4(1) of the Investment Promotion Act, 2004, a foreign investor who commits at least USD 100,000 can apply to the Kenya Investment Authority (KenInvest) for an Investment Certificate. The certificate carries an automatic entitlement to the licences listed in the Act’s Second Schedule and to a defined number of work permits for management staff and for the investors themselves, which removes a layer of case-by-case discretion that would otherwise apply. Separately, the actual work permit application for an investor or a foreign executive runs through the Department of Immigration Services, anchored to the same USD 100,000 investment threshold and supported by the certificate of incorporation, the company’s KRA PIN, its memorandum and articles, the applicant’s passport, and a recommendation letter from KenInvest. KenInvest’s Digital One-Stop-Centre is built to carry an investor through this and the other permitting steps from one point of contact, and continues to offer aftercare support once the company is operating.

The regulatory sequence for a pharmaceutical company market entry once the company exists

The order that works in practice runs: company or branch registration, then KRA PIN registration for the company and its directors, then the statutory employer registrations with NSSF and the Social Health Authority, then the relevant county business permit, and only then the sector-specific steps. For a pharmaceutical business specifically, that means Pharmacy and Poisons Board premises registration, which requires a superintendent pharmacist and the prescribed forms and floor plans, if the company will operate its own licensed premises, and separately, product registration with the Board before any specific product can be marketed in Kenya, followed by an import permit for each consignment that actually enters the country. Our articles on pharmaceutical product registration and compliance and medical devices regulation cover those later steps in detail; this article is about the sequence that gets a company to the point of being able to take them.